Markets:

Overview

News

Currencies

International

Treasuries

Quest Diagnostics (NY:DGX)

229.86 -5.60 (-2.38%)

Streaming Delayed Price Updated: 2:10 PM EDT, Sep 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Quest Diagnostics

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

3 Reasons to Avoid DGX and 1 Stock to Buy Instead

February 20, 2025

Quest has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 13% to $170.50 per share while the index has gained 9.4%.

Via StockStory

Topics Stocks

NeoGenomics (NEO) To Report Earnings Tomorrow: Here Is What To Expect

February 17, 2025

Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) will be reporting results tomorrow morning. Here’s what to look for.

Via StockStory

Grail Shares Spiked Wednesday: What's Going On? ↗

February 12, 2025

Grail shares are trading higher Wednesday after the company announced a new collaboration with Quest Diagnostics aimed at improving provider access to its Galleri multi-cancer early detection test.

Via Benzinga

Labcorp (LH) Reports Earnings Tomorrow: What To Expect

February 05, 2025

Healthcare diagnostics company Labcorp Holdings (NYSE:LH) will be reporting earnings tomorrow before the bell. Here’s what to look for.

Via StockStory

Encompass Health (EHC) Q4 Earnings: What To Expect

February 05, 2025

Health care services provider Encompass Health (NYSE:EHC) will be announcing earnings results tomorrow after the bell. Here’s what investors should know.

Via StockStory

What 6 Analyst Ratings Have To Say About Quest Diagnostics ↗

January 31, 2025

Via Benzinga

Why Quest Diagnostics Stock Was Blasting Higher Today ↗

January 30, 2025

Via The Motley Fool

Analyst Expectations For Quest Diagnostics's Future ↗

January 06, 2025

Via Benzinga

Quest’s (NYSE:DGX) Q4: Beats On Revenue

February 04, 2025

Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 14.6% year on year to $2.62 billion. Its non-GAAP profit...

Via StockStory

Curious about which S&P500 stocks are generating unusual volume on Thursday? Find out below. ↗

January 30, 2025

Discover the S&P500 stocks that are experiencing unusual trading volume in today's session. Find out more about these stocks below.

Via Chartmill

Explore the top gainers and losers within the S&P500 index in today's session. ↗

January 30, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

Quest Diagnostics Stock Hits Over 2-Month High On Q4 Beat, Dividend Hike: Retail Cheer Grows ↗

January 30, 2025

Quest completed eight acquisitions in 2024, including LifeLabs, expanded its advanced diagnostics portfolio, and extended its market reach with new clinical, consumer, and health plan customers.

Via Stocktwits

How Is The Market Feeling About Quest Diagnostics? ↗

December 31, 2024

Via Benzinga

The Analyst Landscape: 8 Takes On Quest Diagnostics ↗

December 10, 2024

Via Benzinga

(DGX) - Analyzing Quest Diagnostics's Short Interest ↗

December 02, 2024

Via Benzinga

Quest Diagnostics Delivers Q4 Earnings Beat: The Details ↗

January 30, 2025

Quest Diagnostics reported fourth-quarter revenue of $2.62 billion, beating analyst estimates of $2.58 billion, according to Benzinga Pro. The company reported fourth-quarter adjusted earnings of $2.23...

Via Benzinga

Quest Diagnostics EPS Tops Predictions ↗

January 30, 2025

Quest Diagnostics saw robust growth in earnings and revenue, surpassing expectations for Q4 2024.

Via The Motley Fool

IBM Posts Upbeat Earnings, Joins Oshkosh, Las Vegas Sands, Nokia, Quest Diagnostics And Other Big Stocks Moving Higher On Thursday ↗

January 30, 2025

Via Benzinga

Friday's session: top gainers and losers in the S&P500 index ↗

January 24, 2025

Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

How Is The Market Feeling About Quest Diagnostics? ↗

November 11, 2024

Via Benzinga

Earnings Scheduled For January 30, 2025 ↗

January 30, 2025

Via Benzinga

Tesla To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday ↗

January 06, 2025

Via Benzinga

This Boeing Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday ↗

January 06, 2025

Via Benzinga

Quest Diagnostics (NYSE: DGX) And Mainz Biomed (NASDAQ: MYNZ) Team Up To Commercialize ColoAlert Early Cancer Detection Screening In The U.S.

December 20, 2024

Quest Diagnostics (NYSE: DGX) And Mainz Biomed (NASDAQ: MYNZ) Team Up To Commercialize ColoAlert Early Cancer Detection Screening In The U.S.

Via News Direct

Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services ↗

December 19, 2024

U.S. healthcare spending grew 7.5% to $4.9 trillion in 2023, with hospital care and prescription drugs driving costs. Private insurance accounted for 30% of total spending.

Via Benzinga

Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test

December 19, 2024

Quest to Support Mainz Biomed’s ReconAAsense FDA Study and Has Option to Commercialize Test Kit Assuming FDA Approval

From Mainz BioMed NV

Via GlobeNewswire

Tesla To Rally More Than 11%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

December 17, 2024

Via Benzinga

This Tesla Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday ↗

December 17, 2024

Via Benzinga

Guardant Health Stock Sees RS Rating Jump To 83 ↗

November 20, 2024

On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83.

Via Investor's Business Daily

Navigating Earnings Season: Weather Any Storm ↗

November 16, 2024

The consequences of hurricanes like Helene and Milton are—typically—quickly shrugged aside by markets as one-off events. That is mostly correct. But not entirely so. For some companies, the revenue and...

Via Talk Markets

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.